Tower Research Capital (TRC)’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.4K | Buy |
3,214
+846
| +36% | +$13.5K | ﹤0.01% | 2951 |
|
|
2025
Q1 | $36K | Buy |
2,368
+722
| +44% | +$11K | ﹤0.01% | 2467 |
|
|
2024
Q4 | $33.4K | Buy |
1,646
+1,232
| +298% | +$25K | ﹤0.01% | 2825 |
|
|
2024
Q3 | $10.6K | Sell |
414
-1,234
| -75% | -$31.7K | ﹤0.01% | 3732 |
|
|
2024
Q2 | $21.2K | Buy |
1,648
+240
| +17% | +$3.09K | ﹤0.01% | 3729 |
|
|
2024
Q1 | $32.2K | Buy |
1,408
+814
| +137% | +$18.6K | ﹤0.01% | 2592 |
|
|
2023
Q4 | $15.6K | Buy |
594
+498
| +519% | +$13K | ﹤0.01% | 3820 |
|
|
2023
Q3 | $2.7K | Buy |
+96
| New | +$2.7K | ﹤0.01% | 5113 |
|
|
2023
Q2 | – | Sell |
-867
| Closed | -$16K | – | 6336 |
|
|
2023
Q1 | $16K | Sell |
867
-36
| -4% | -$664 | ﹤0.01% | 3738 |
|
|
2022
Q4 | $9K | Buy |
903
+39
| +5% | +$389 | ﹤0.01% | 4275 |
|
|
2022
Q3 | $23K | Buy |
864
+527
| +156% | +$14K | ﹤0.01% | 3828 |
|
|
2022
Q2 | $15K | Sell |
337
-464
| -58% | -$20.7K | ﹤0.01% | 4094 |
|
|
2022
Q1 | $79K | Buy |
801
+730
| +1,028% | +$72K | ﹤0.01% | 2380 |
|
|
2021
Q4 | $11K | Sell |
71
-8
| -10% | -$1.24K | ﹤0.01% | 4459 |
|
|
2021
Q3 | $10K | Buy |
79
+73
| +1,217% | +$9.24K | ﹤0.01% | 4338 |
|
|
2021
Q2 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 5267 |
|